Artielle ImmunoTherapeutics' Convertible Note - III Round

Artielle ImmunoTherapeutics raised a round of funding on May 15, 2008.

Artielle ImmunoTherapeutics is developing a novel, first-in-class platform of biologic drugs to treat a range of inflammatory and degenerative diseases. Artielle's initial therapeutic focus is on neur…

Articles about Artielle ImmunoTherapeutics' Convertible Note - III Round: